Mintz Achieves Ten Years of Consecutive Revenue Growth

Mintz advised the underwriters in connection with a $90 million underwritten offering by Rezolute, Inc. of 20,786,923 shares of common stock and pre-funded warrants to purchase up to 6,905,385 shares of common stock. The deal team was led by Life Sciences Practice Co-chair Bill Hicks, Securities & Capital Markets Co-chair John Rudy, and Member Alok Choksi, along with support from other Mintz attorneys.

Life Sciences Practice Co-chair Bill Hicks joined host Nessan Bermingham on the Between the Biotech Waves podcast to explore key trends shaping the biotech sector. Their conversation covered recent market dynamics, the evolving impact of tariffs, and the broader implications for the US and global markets.

Mintz has once again been recognized as one of the most active and high-performing International Trade Commission (ITC) law firms in the Patexia 2025 ITC Intelligence Report. Several of the firm’s intellectual property practitioners were also named among the top-performers in the country.

The evolving DEI landscape presents complex legal, reputational, and operational challenges, demanding a strategic and practical, business-focused approach. Our DEI Task Force offers tailored insights and guidance to help clients navigate this rapidly shifting environment with confidence and compliance.